In this video, we delve into the recent FDA announcement accelerating the approval process for a groundbreaking drug designed to extend the life expectancy of large dog breeds. The manufacturer, Loyal, has kept specific details confidential but claims to meet the criteria for expanded conditional approval, opening new avenues for innovative animal therapies. We explore the implications of this expedited pathway and Loyal's research on the drug, LOY-001, aiming for market entry by 2026, as reported by the New York Times.
Celine Halioua, Loyal's founder and CEO, discusses the company's ambition to claim at least a one-year extension of healthy lifespan. Discover how LOY-001 targets the growth-promoting hormone IGF-1, addressing the elevated levels in larger breeds and potentially altering their life spans. We also touch upon ethical concerns raised by experts, including bioethicist Rebecca Walker and veterinarian Kate Creevy.
Stay informed about the latest developments in canine health and the future of innovative therapies. Don't miss this comprehensive exploration of the FDA's move and its potential impact on our furry friends!
#FDA #DogHealth #AnimalTherapy #Loyal #LOY001 #PetCare #LifeExtension #VeterinaryMedicine #Innovation #FDAApproval #CanineResearch #PetWellness #AnimalHealthcare #Bioethics #DogLovers #HealthyPets #PetScience #MedicalAdvancements #DogBreeds #PetQualityofLife
Music "Space Jazz" Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 4.0 License. http://creativecommons.org/licenses/b...
Watch video FDA Approval for Dog Life Extension Drug online without registration, duration hours minute second in high quality. This video was added by user Netgrows Tech 04 December 2023, don't forget to share it with your friends and acquaintances, it has been viewed on our site 61 once and liked it 3 people.